Using organoids embedded in a novel immune organ-on-chip technology, the team observed that immune cells from lymphoma survivors treated with certain immunotherapies do not organize themselves into ...

For the quarter ended September 30, 2024, the Company had a loss from operations of $2.3 million, a 26% year-over-year improvement from $3.1 million for the comparable period of 2023, and a 9% ...

In the world of cell therapy, Silicon Valley has long recognized that technological innovation is the key to solving ...

Scientists at Pohang University of Science and Technology (POSTECH) and ShanghaiTech University have achieved a breakthrough ...

A research team from the University of Basel has succeeded in synthesizing simple, environmentally sensitive cells complete ...

Instead of sending tourists to space, scientists have found a more practical use for the final frontier: growing better ...

Cord blood is increasingly being stored by parents everywhere, who are seeking to preserve their child's stem cells as they ...

Because AB126 is made up of allogenic neural exosomes derived from neural stem cells, it means that it possesses many ... The ...

Model used to create a cellular 'hologram' of a mouse embryo could be used to visualize development in any species.

(NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it has ...